In some clinical situations, tumour diagnostic techniques may fail to localise precancerous lesions and superficial tumours, e.g. in the tracheobronchial area, the oesophagus, the urinary bladder and the ear/nose throat region. Biopsy sampling is often performed in a blind way during conventional tumour screening procedures; hence, the malignant areas may not be localised. Therefore, there is a need to develop more sensitive methods. Laser-induced fluorescence (LIF) in conjunction with different photosensitisers is a new, rapidly evolving modality which has exhibited promising results in early tumour localisation (Cortese et al., 1979; Doiron et al., 1979) . Most frequently, various derivatives of porphyrins, such as haematoporphyrin derivative (HpD) (commercial name Photofrin), have been used. These substances give rise to a characteristic red fluorescence when excited in the UV or near-UV region. As accumulation of the photosensitising substance occurs in premalignant and malignant areas, diseased tissue is characterised by a higher fluorescence intensity in the red wavelength region, compared with most nondiseased tissues. For example, LIF of tumours in the bronchial tree and the urinary bladder in conjunction with low-dose HpD in clinical diagnostics has been performed (Lam et al., 1990; Baert et al., 1992) . Premalignant and in situ malignant lesions were localised.
Although HpD has tumour-localising properties with a discnrmination towards normal tissue of about 2-3:1 for various malignant lesions, several factors limit its widespread use as a photodiagnostic agent, including the heterogeneous chemical composition and the presence of non-fluorescent aggregated material, the limited selectivity and the prolonged persistence of general cutaneous photosensitivity if administered in therapeutic doses (Dougherty, 1987; Razum et al., 1987) . The development of new sensitisers has mainly emphasised their therapeutic effects, including high single oxygen yield for the induction of tumour necrosis and light absorption at wavelengths close to 700nm for deep light penetration. Also, less skin photosensitisation, as compared with HpD, is a major goal. Substances which have been studied include phthalocyanines (Pcs) (Spikes, 1986) , various derivatives of cholorphyll, chlorins (Nelson et al., 1987) , purpurins (Kessel, 1989) and some additional porphyrin derivatives. Lately, 6-aminolaevulinc acid (ALA) (Kennedy et al.. 1990 : Kennedy & Pottier, 1992 Grant et al.. 1993; Svanberg et al.. 1994 ), a precursor to haem, and benzoporphyrin derivative (BPD) (Richter et al., 1987 (Richter et al., , 1988 (Richter et al., , 1990 have been investigated. MACE (mono-aspartyl chlorin ed) does not induce any cutaneous photosensitivity at all, because of a fast clearance rate (Nelson et al.. 1987) .
Recently, a new class of tumour-localising substances has been developed solely for tumour demarcation capability, without any photosensitising effect. These substances consist of carotenoid polyenes covalently linked to porphyrins, in which the tetraaryl porphyrin moiety carries either three methyl (Me) or three methoxy (OMe) groups (Reddi et al., 1994) . These carotenoporphyrins (CPs) have the unique capability of mimicking carotenoid photoprotection such as occurs in the photosynthetic reaction centres of green plants. The carotene moiety rapidly quenches the porphyrin triplet state, thus preventing the porphyrin-sensitised formation of cytotoxic 102 (Gust et al., 1992a) . Accordingly, CPs cannot be used for photodynamic therapy (PDT), but are valuable alternatives for LIF-mediated detection of malignant lesions, because they are designed to reduce damage to skin and other organs.
In this paper, we report on laser-induced fluorescence measurements in mice injected with CP(Me)3 or CP(OMe)3. The acquired spectra were used to characterise a transplanted fibrosarcoma and normal muscle (peritumoral tissue), following excitation at 425 nm. Similar studies have been carried out previously using other substances such as HpD (Svanberg et al., 1986) In addition to simply using the substance-related fluorescence, the endogenous fluorescence emanating from natural fluorophores in the tissue may also be included in order to enhance the tumour demarcation towards healthy peritumoral tissue. It has been shown that the autofluorescence, with its intensity maximum at about 500 nm when excited in the near-UV region, shows a lower intensity in tumour than in normal tissue (Ankerst et al., 1984; Profio & Sarnaik, 1984; Andersson-Engels et al., 1989b , 1991a Cothren et al., 1990; Hung et al., 1991; Baert et al., 1992) . To some extent, the reason for the decreased autofluorescence seems to be a decrease in the amount of oxidised forms of flavins in malignant tissue (Hung et al., 1991) . Another reason for the decrease in tumour autofluorescence might be a change in the relative amounts of the highly fluorescent reduced form of nicotinamide adenine dinucleotide (NADH) and the weakly fluorescent oxidised form NAD+ in malignant tumours (Svanberg et al., 1986; Lohmann & Hugo, 1989; AnderssonEngels et al., 1991b Baert et al., 1992) . By measuring the ratio between the exogenous fluorescence, which increases in tumour, and the autofluorescence, which decreases, the tumour/peritumoral tissue demarcation is enhanced. In addition, the designation of a dimensionless ratio also implies an insensitivity to fluctuations in excitation and detection equipment and variations in surface topography or differences in the distance between the optical fibre and the tissue being analysed.
Material nd mthods

Chemicals
The carotenoporphyrins were synthesised at Arizona State University according to the procedures previously described (Gust et al., 1992b) . Their structural formulas are shown in Reddi et al. (1994) . A 5 mg aliquot of carotenoporphyrin was added to 0.5 ml of Cremophor and sonicated until the CP was completely dispersed in the emulsifier agent. The suspension was added to 0.15 ml of absolute ethanol, sonicated again and taken to a final volume of lOml by the stepwise addition of a saline solution at pH 7.4. The final Cremophor emulsion was filtered through a 0.45pm filter and the CP concentration (0.45-0.5 mg) was determined spectrophotometrically after a 1:200 dilution of a small aliquot of emulsion in absolute ethanol and using an extinction coefficient of 
Anbnals and tumour
Female Balb/c mice (18-22 g body weight) received 0.2 ml of a cell suspension containing 106 MS-2 fibrosarcoma cells ml-'. The tumour grows intramuscularly in the right hind leg 6 days before the first day of measurement (Reddi et al., 1994) .
In vivo and ex vivo fluorescence measurements Figure 2 illustrates the method used for the fluorescence measurements. A scan over healthy muscle and tumour tissue was performed, and also, in the ex vivo situation, a reference measurement in the non-diseased left hind legs of the mice was taken. The in vivo scans were performed after an i.p. injection of approximately 0.09 ml Ketalar (50 mg ml-') from Parke Davis, Milan. After the animal was anaesthetised, the skin over the tumour and surrounding mucscle was cut open, the scan was performed and the animal was sacrificed with ether. In the dead mice, the optical fibre was inserted a few millimetres into the tissue, where fluorescence measurements were carried out.
Two points were measured at 5 and 2 mm outside the tumour in healthy muscle. Inside the tumour, five points were chosen for measurements, the first and last point being about I mm from the tumour border with healthy muscle, and the other points being equally spaced along a line bisecting the tumour. The diameters of the tumours were about 15 mm at the time of analysis. The tumour model used (fibrosarcoma MS-2) was not optimal in that necrotic areas appeared rather quickly. No major necrosis was present in the measurements 3 and 24 h post injection, and the few points where recordings had been taken from necrotic areas were deleted before the data analysis was performed. In the case of the 48 h measurements, the amount of necrosis had increased somewhat, but the same procedure was followed. For the 96 h groups, no points whatsoever were deleted, which is reflected in the great standard deviations of the fluorescence signal. This is especially true for the substance CP(Me), which, at 96 h, exhibited huge standard deviations as a consequence of very necrotic tumours. The necrosis also predisposed to haemorrhages, which further interfered with the fluorescence because of light reabsorption by blood in the green-yellow spectral region.
Equipment
The optical set-up used for the recordings of laser-induced fluorescence is similar to one previously described (Andersson-Engels et al., 1989a , 1991a and will only be briefly described here. The excitation source was a nitrogen laser (Laser Science VSL-337ND) used alone or as pump source for a compact dye laser (Laser Science DLM220). The output pulse energy of the nitrogen laser was 180iJ, the pulse duration 3 ns and the repetition rate about 10 Hz. For the dye laser the output energy was up to 20 pU and the wavelength could be varied by turning a grating. For these measurements, the wavelength was set at 425 nm. The laser light was focused onto the tip of a fluorescence-free 600 im optical fibre and the distal end of the fibre was held in contact with the animal tissue. The fluorescence guided back through the same fibre was transmitted through a dichroic mirror, which at the same time blocks out the reflected excitation light, and focused at the 100 #m entrance slit of a polychromator (Acton SP-275). A cut-off filter at 455 nm was used to remove any residual elastically scattered excitation light. The detector was a 576 x 384 pixel image-intensified charge-coupled device (CCD) camera (Spectroscopy Instr. ICCD-576G/R) cooled to -20C. In total, about 2,500 fluorescence spectra were recorded and stored on floppy discs for evaluation. The fluorescence from 50 laser pulses was integrated for each spectrum, although in most cases useful signal-to-noise was obtained in single shot.
Results and DEscassio. The carotenoporphyrin-specific fluorescence is characterised by two peaks. In the case of CP(Me)3 the peaks are at 654 and 720 nm, whereas they are slightly shifted to the red in the case of CP(OMe)3, appearing at 658 and 722 nm. The fluorescence intensities at the peaks were evaluated with the background fluorescence subtracted, as marked in the Figure. The first substance-specific free-standing peak is denoted 'A' and the endogenous fluorescence 'B'. The ratio between A and the second substance-related peak varied slightly according to substance injected and time elapsed since injection. The Figure 2b for CP(OMe)3 could perhaps be attributed to the greater build-up of the substance CP(OMe) than of CP(Me)3 in tumour, as discussed in Reddi et al. (1994) . In several spectra, as seen in some of the graphs in Figure  2 , a small peak at approximately 590 nm is observed. The same peak was also seen in the non-injected control animals.
A similar peak has been observed also in cinical fluorescence measurements, e.g. in astrocytomas and human tonsil cancers (Andersson-Engels et al., 1991a; Str6mblad et al., submitted). It is probably attributable to some endogenous porphyrin, perhaps bacterially synthesised (Harris & Werkhaven, 1987) . Another possibility is that the fluorescence is related to some metalloporphyrin, probably zinc haematoporphyrin (ZnHp), which is synthesised by the tumour itself (Moan, 1986; Plus, 1992) . No significant difference between tumour and normal tissue could be seen in the fluorescence intensity at this wavelength, in the measurements carried out 3 and 24 h post injection. This is true for both the injected and the noninjected control animals, evaluated at corresponding times.
The intensities were in the same range for the control animals and the animals evaluated 3 h after administration of the two carotenoporphyrins, which all had had their tumours transplanted at the same time. In the measurements 48 and % h post aministration, with much necrosis, the tumours exhibited somewhat higher intensities at 590 nm, but with no great significance, owing to large fluctuations in the signal.
TIhe evaluated data from all the tumour scans are shown in Figure 3a for CP(Me) and Figure 3 clearly shows that the main fluorescence peak (A) has a larger intensity in tumour for both substances. On average, the intensity increase in tumour compared with muscle is about 5 for CP(Me) and 5.6-6.8 for CP(OMe).
An important property of both substances is the tumour selectivity demonstrated in the scans with the registration 2 mm outside the tumour, in muscle, where the intensity is approximately equal to the point 5 mm outside the tumour, i.e. no increase is seen on approaching the tumour. The fluorescence intensity is not elevated until the tumour is reached. Except in the case of the data 48 and 96 h post injection with CP(Me), the standard deviations are small.
The intensity of the carotenoporphyrin-related fluorescence (A) increases over time up to 48 h for CP(Me) and then starts falling off, probably reflecting an initial build-up of the substance in the tissues and then a consecutive claring. In the case of CP(OMe)3, A decreases slightly when going from 3 h to 24 h post injection, then it remains relatively constant up to 48 h and, finally, falls off during the following 48 h. (Note the change in scales with increasing times.) This is probably because the substance is cleared from the tissues. The tumour/muscle ratio, in terms of the free-standing peak A is, for CP(Me)3, 5.5 at 3 h, 5.9 at 24 h, 7.5 at 48 h and 3.4 at 96 h. The corresponding ratio for CP(OMe) is 3.8, 5.4, 9.1 and 8.4. In the case of CP(Me), the tumour/muscle ratio remains relatively constant over time, since the fluorescence intensities decrease in the same proportions in muscle and in tumour. For CP(OMe)3, the tumour/muscle ratio increases at 48 and 96 h post administration, indicating that the substance is retained for a longer time in tumour than in healthy muscle. If the endogenous fluorescence is included, forming the ratio A/B, the tumour/muscle ratio is enhanced to 7.3 at 3 h, 9.5 at 24 h, 12.5 at 48 h and 7.9 at % h, and 8.2 at 3 h, 9.3 at 24 h, 10.3 at 48 h and 11.2 at 96 h for CP(Me) and CP(OMe)3 respectively. The increase in the tumour/muscle ratio varies between 27% and 400%, with an average of about 95%, when the autofluorescence is included. The extremely high values of several hundred per cent contrast enhancement probably are due to a reduction in the autofluorescence because of necrosis, as pointed out previously, which also means that the contrast is enhanced at the expense of a greater uncertainty in the results (see, for Figure 4 . The advantage of forming the ratio is that it is dimensionless, tumour/peritumoral muscle ratio is plotted for the two which means that the results are rather insensitive to fluctuacarotenoporphyrins as a function of time after administrations in the excitation source and the detection equipment, as tion. Figure 4a shows the tumour/muscle ratio using the well as to topographic and distance differences in the substance-related peak., A, as an average of all the in vivo and measurement procedure. 
